Wen et al. (2020) found that DANCR could not only improve HNRNPA1 expression via DANCR/miR-140-3p/HNRNPA1 axis but also bind to HNRNPA1 protein and inhibit its degradation. However, DANCR was also considered as a tumor suppressor due to the suppression of Wnt/β-catenin signaling pathway in HCC (Song et al., 2020). The gene discussed is HNRNPA1; the disease is neoplasm.